Evidence-based clinical practice guidelines for inflammatory bowel disease

Katsuyoshi Matsuoka, Taku Kobayashi, Fumiaki Ueno, Toshiyuki Matsui, Fumihito Hirai, Nagamu Inoue, Jun Kato, Kenji Kobayashi, Kiyonori Kobayashi, Kazutaka Koganei, Reiko Kunisaki, Satoshi Motoya, Masakazu Nagahori, Hiroshi Nakase, Fumio Omata, Masayuki Saruta, Toshiaki Watanabe, Toshiaki Tanaka, Takanori Kanai, Yoshinori Noguchi & 7 others Ken ichi Takahashi, Kenji Watanabe, Toshifumi Hibi, Yasuo Suzuki, Mamoru Watanabe, Kentaro Sugano, Tooru Shimosegawa

Research output: Contribution to journalReview article

42 Citations (Scopus)

Abstract

Inflammatory bowel disease (IBD) is a chronic disorder involving mainly the intestinal tract, but possibly other gastrointestinal and extraintestinal organs. Although etiology is still uncertain, recent knowledge in pathogenesis has accumulated, and novel diagnostic and therapeutic modalities have become available for clinical use. Therefore, the previous guidelines were urged to be updated. In 2016, the Japanese Society of Gastroenterology revised the previous versions of evidence-based clinical practice guidelines for ulcerative colitis (UC) and Crohn’s disease (CD) in Japanese. A total of 59 clinical questions for 9 categories (1. clinical features of IBD; 2. diagnosis; 3. general consideration in treatment; 4. therapeutic interventions for IBD; 5. treatment of UC; 6. treatment of CD; 7. extraintestinal complications; 8. cancer surveillance; 9. IBD in special situation) were selected, and a literature search was performed for the clinical questions with use of the MEDLINE, Cochrane, and Igaku Chuo Zasshi databases. The guidelines were developed with the basic concept of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Recommendations were made using Delphi rounds. This English version was produced and edited based on the existing updated guidelines in Japanese.

Original languageEnglish
Pages (from-to)305-353
Number of pages49
JournalJournal of Gastroenterology
Volume53
Issue number3
DOIs
Publication statusPublished - 2018 Mar 1
Externally publishedYes

Fingerprint

Evidence-Based Practice
Inflammatory Bowel Diseases
Practice Guidelines
Guidelines
Ulcerative Colitis
Crohn Disease
Gastroenterology
MEDLINE
Databases
Therapeutics
Neoplasms

Keywords

  • Consensus
  • Crohn’s disease
  • Evidence
  • Guidelines
  • Inflammatory bowel disease
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Matsuoka, K., Kobayashi, T., Ueno, F., Matsui, T., Hirai, F., Inoue, N., ... Shimosegawa, T. (2018). Evidence-based clinical practice guidelines for inflammatory bowel disease. Journal of Gastroenterology, 53(3), 305-353. https://doi.org/10.1007/s00535-018-1439-1

Evidence-based clinical practice guidelines for inflammatory bowel disease. / Matsuoka, Katsuyoshi; Kobayashi, Taku; Ueno, Fumiaki; Matsui, Toshiyuki; Hirai, Fumihito; Inoue, Nagamu; Kato, Jun; Kobayashi, Kenji; Kobayashi, Kiyonori; Koganei, Kazutaka; Kunisaki, Reiko; Motoya, Satoshi; Nagahori, Masakazu; Nakase, Hiroshi; Omata, Fumio; Saruta, Masayuki; Watanabe, Toshiaki; Tanaka, Toshiaki; Kanai, Takanori; Noguchi, Yoshinori; Takahashi, Ken ichi; Watanabe, Kenji; Hibi, Toshifumi; Suzuki, Yasuo; Watanabe, Mamoru; Sugano, Kentaro; Shimosegawa, Tooru.

In: Journal of Gastroenterology, Vol. 53, No. 3, 01.03.2018, p. 305-353.

Research output: Contribution to journalReview article

Matsuoka, K, Kobayashi, T, Ueno, F, Matsui, T, Hirai, F, Inoue, N, Kato, J, Kobayashi, K, Kobayashi, K, Koganei, K, Kunisaki, R, Motoya, S, Nagahori, M, Nakase, H, Omata, F, Saruta, M, Watanabe, T, Tanaka, T, Kanai, T, Noguchi, Y, Takahashi, KI, Watanabe, K, Hibi, T, Suzuki, Y, Watanabe, M, Sugano, K & Shimosegawa, T 2018, 'Evidence-based clinical practice guidelines for inflammatory bowel disease', Journal of Gastroenterology, vol. 53, no. 3, pp. 305-353. https://doi.org/10.1007/s00535-018-1439-1
Matsuoka, Katsuyoshi ; Kobayashi, Taku ; Ueno, Fumiaki ; Matsui, Toshiyuki ; Hirai, Fumihito ; Inoue, Nagamu ; Kato, Jun ; Kobayashi, Kenji ; Kobayashi, Kiyonori ; Koganei, Kazutaka ; Kunisaki, Reiko ; Motoya, Satoshi ; Nagahori, Masakazu ; Nakase, Hiroshi ; Omata, Fumio ; Saruta, Masayuki ; Watanabe, Toshiaki ; Tanaka, Toshiaki ; Kanai, Takanori ; Noguchi, Yoshinori ; Takahashi, Ken ichi ; Watanabe, Kenji ; Hibi, Toshifumi ; Suzuki, Yasuo ; Watanabe, Mamoru ; Sugano, Kentaro ; Shimosegawa, Tooru. / Evidence-based clinical practice guidelines for inflammatory bowel disease. In: Journal of Gastroenterology. 2018 ; Vol. 53, No. 3. pp. 305-353.
@article{374d962a34c9409d8e5ca12e9d328d4e,
title = "Evidence-based clinical practice guidelines for inflammatory bowel disease",
abstract = "Inflammatory bowel disease (IBD) is a chronic disorder involving mainly the intestinal tract, but possibly other gastrointestinal and extraintestinal organs. Although etiology is still uncertain, recent knowledge in pathogenesis has accumulated, and novel diagnostic and therapeutic modalities have become available for clinical use. Therefore, the previous guidelines were urged to be updated. In 2016, the Japanese Society of Gastroenterology revised the previous versions of evidence-based clinical practice guidelines for ulcerative colitis (UC) and Crohn’s disease (CD) in Japanese. A total of 59 clinical questions for 9 categories (1. clinical features of IBD; 2. diagnosis; 3. general consideration in treatment; 4. therapeutic interventions for IBD; 5. treatment of UC; 6. treatment of CD; 7. extraintestinal complications; 8. cancer surveillance; 9. IBD in special situation) were selected, and a literature search was performed for the clinical questions with use of the MEDLINE, Cochrane, and Igaku Chuo Zasshi databases. The guidelines were developed with the basic concept of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Recommendations were made using Delphi rounds. This English version was produced and edited based on the existing updated guidelines in Japanese.",
keywords = "Consensus, Crohn’s disease, Evidence, Guidelines, Inflammatory bowel disease, Ulcerative colitis",
author = "Katsuyoshi Matsuoka and Taku Kobayashi and Fumiaki Ueno and Toshiyuki Matsui and Fumihito Hirai and Nagamu Inoue and Jun Kato and Kenji Kobayashi and Kiyonori Kobayashi and Kazutaka Koganei and Reiko Kunisaki and Satoshi Motoya and Masakazu Nagahori and Hiroshi Nakase and Fumio Omata and Masayuki Saruta and Toshiaki Watanabe and Toshiaki Tanaka and Takanori Kanai and Yoshinori Noguchi and Takahashi, {Ken ichi} and Kenji Watanabe and Toshifumi Hibi and Yasuo Suzuki and Mamoru Watanabe and Kentaro Sugano and Tooru Shimosegawa",
year = "2018",
month = "3",
day = "1",
doi = "10.1007/s00535-018-1439-1",
language = "English",
volume = "53",
pages = "305--353",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Evidence-based clinical practice guidelines for inflammatory bowel disease

AU - Matsuoka, Katsuyoshi

AU - Kobayashi, Taku

AU - Ueno, Fumiaki

AU - Matsui, Toshiyuki

AU - Hirai, Fumihito

AU - Inoue, Nagamu

AU - Kato, Jun

AU - Kobayashi, Kenji

AU - Kobayashi, Kiyonori

AU - Koganei, Kazutaka

AU - Kunisaki, Reiko

AU - Motoya, Satoshi

AU - Nagahori, Masakazu

AU - Nakase, Hiroshi

AU - Omata, Fumio

AU - Saruta, Masayuki

AU - Watanabe, Toshiaki

AU - Tanaka, Toshiaki

AU - Kanai, Takanori

AU - Noguchi, Yoshinori

AU - Takahashi, Ken ichi

AU - Watanabe, Kenji

AU - Hibi, Toshifumi

AU - Suzuki, Yasuo

AU - Watanabe, Mamoru

AU - Sugano, Kentaro

AU - Shimosegawa, Tooru

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Inflammatory bowel disease (IBD) is a chronic disorder involving mainly the intestinal tract, but possibly other gastrointestinal and extraintestinal organs. Although etiology is still uncertain, recent knowledge in pathogenesis has accumulated, and novel diagnostic and therapeutic modalities have become available for clinical use. Therefore, the previous guidelines were urged to be updated. In 2016, the Japanese Society of Gastroenterology revised the previous versions of evidence-based clinical practice guidelines for ulcerative colitis (UC) and Crohn’s disease (CD) in Japanese. A total of 59 clinical questions for 9 categories (1. clinical features of IBD; 2. diagnosis; 3. general consideration in treatment; 4. therapeutic interventions for IBD; 5. treatment of UC; 6. treatment of CD; 7. extraintestinal complications; 8. cancer surveillance; 9. IBD in special situation) were selected, and a literature search was performed for the clinical questions with use of the MEDLINE, Cochrane, and Igaku Chuo Zasshi databases. The guidelines were developed with the basic concept of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Recommendations were made using Delphi rounds. This English version was produced and edited based on the existing updated guidelines in Japanese.

AB - Inflammatory bowel disease (IBD) is a chronic disorder involving mainly the intestinal tract, but possibly other gastrointestinal and extraintestinal organs. Although etiology is still uncertain, recent knowledge in pathogenesis has accumulated, and novel diagnostic and therapeutic modalities have become available for clinical use. Therefore, the previous guidelines were urged to be updated. In 2016, the Japanese Society of Gastroenterology revised the previous versions of evidence-based clinical practice guidelines for ulcerative colitis (UC) and Crohn’s disease (CD) in Japanese. A total of 59 clinical questions for 9 categories (1. clinical features of IBD; 2. diagnosis; 3. general consideration in treatment; 4. therapeutic interventions for IBD; 5. treatment of UC; 6. treatment of CD; 7. extraintestinal complications; 8. cancer surveillance; 9. IBD in special situation) were selected, and a literature search was performed for the clinical questions with use of the MEDLINE, Cochrane, and Igaku Chuo Zasshi databases. The guidelines were developed with the basic concept of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Recommendations were made using Delphi rounds. This English version was produced and edited based on the existing updated guidelines in Japanese.

KW - Consensus

KW - Crohn’s disease

KW - Evidence

KW - Guidelines

KW - Inflammatory bowel disease

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=85041923106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041923106&partnerID=8YFLogxK

U2 - 10.1007/s00535-018-1439-1

DO - 10.1007/s00535-018-1439-1

M3 - Review article

VL - 53

SP - 305

EP - 353

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - 3

ER -